SAVA Annual EBITDA
-$104.43 M
-$25.71 M-32.66%
31 December 2023
Summary:
As of January 23, 2025, SAVA annual earnings before interest, taxes, depreciation & amortization is -$104.43 million, with the most recent change of -$25.71 million (-32.66%) on December 31, 2023. During the last 3 years, it has fallen by -$97.66 million (-1442.50%). SAVA annual EBITDA is now -432.94% below its all-time high of $31.36 million, reached on December 31, 2013.SAVA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SAVA Quarterly EBITDA
-$30.36 M
+$30.74 M+50.30%
30 September 2024
Summary:
As of January 23, 2025, SAVA quarterly earnings before interest, taxes, depreciation & amortization is -$30.36 million, with the most recent change of +$30.74 million (+50.30%) on September 30, 2024. Over the past year, it has dropped by -$2.88 million (-10.47%). SAVA quarterly EBITDA is now -192.28% below its all-time high of $32.90 million, reached on December 31, 2013.SAVA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SAVA TTM EBITDA
-$133.52 M
-$2.88 M-2.20%
30 September 2024
Summary:
As of January 23, 2025, SAVA TTM earnings before interest, taxes, depreciation & amortization is -$133.52 million, with the most recent change of -$2.88 million (-2.20%) on September 30, 2024. Over the past year, it has dropped by -$30.98 million (-30.21%). SAVA TTM EBITDA is now -525.70% below its all-time high of $31.36 million, reached on December 31, 2013.SAVA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SAVA EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -32.7% | -10.5% | -30.2% |
| 3 y3 years | -1442.5% | -10.5% | -30.2% |
| 5 y5 years | -1483.9% | -10.5% | -30.2% |
SAVA EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -223.0% | at low | -114.9% | +50.3% | -312.9% | at low |
| 5 y | 5-year | -2030.7% | at low | -2221.4% | +50.3% | -2696.2% | at low |
| alltime | all time | -432.9% | at low | -192.3% | +50.3% | -525.7% | at low |
Cassava Sciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$30.36 M(-50.3%) | -$133.52 M(+2.2%) |
| June 2024 | - | -$61.10 M(+211.4%) | -$130.64 M(+33.4%) |
| Mar 2024 | - | -$19.62 M(-12.5%) | -$97.93 M(-6.2%) |
| Dec 2023 | -$104.43 M(+32.7%) | -$22.43 M(-18.4%) | -$104.43 M(+1.8%) |
| Sept 2023 | - | -$27.49 M(-3.2%) | -$102.54 M(+6.7%) |
| June 2023 | - | -$28.39 M(+8.7%) | -$96.10 M(+10.0%) |
| Mar 2023 | - | -$26.12 M(+27.1%) | -$87.33 M(+10.9%) |
| Dec 2022 | -$78.72 M(+143.5%) | -$20.55 M(-2.4%) | -$78.72 M(+8.9%) |
| Sept 2022 | - | -$21.05 M(+7.3%) | -$72.30 M(+18.9%) |
| June 2022 | - | -$19.62 M(+12.1%) | -$60.80 M(+31.3%) |
| Mar 2022 | - | -$17.51 M(+23.9%) | -$46.31 M(+43.2%) |
| Dec 2021 | -$32.33 M(+377.6%) | -$14.13 M(+48.1%) | -$32.33 M(+55.3%) |
| Sept 2021 | - | -$9.54 M(+86.0%) | -$20.83 M(+63.7%) |
| June 2021 | - | -$5.13 M(+45.2%) | -$12.72 M(+41.4%) |
| Mar 2021 | - | -$3.53 M(+34.7%) | -$8.99 M(+32.9%) |
| Dec 2020 | -$6.77 M(+38.1%) | -$2.62 M(+82.7%) | -$6.77 M(+18.6%) |
| Sept 2020 | - | -$1.44 M(+2.4%) | -$5.71 M(+13.3%) |
| June 2020 | - | -$1.40 M(+7.3%) | -$5.04 M(+5.5%) |
| Mar 2020 | - | -$1.31 M(-16.3%) | -$4.78 M(-2.6%) |
| Dec 2019 | -$4.90 M(-25.7%) | -$1.56 M(+104.2%) | -$4.90 M(+20.4%) |
| Sept 2019 | - | -$765.00 K(-32.9%) | -$4.07 M(-11.0%) |
| June 2019 | - | -$1.14 M(-20.5%) | -$4.57 M(-22.2%) |
| Mar 2019 | - | -$1.43 M(+95.6%) | -$5.88 M(-10.9%) |
| Dec 2018 | -$6.59 M(-44.5%) | -$733.00 K(-42.1%) | -$6.59 M(-20.2%) |
| Sept 2018 | - | -$1.27 M(-48.2%) | -$8.27 M(-13.7%) |
| June 2018 | - | -$2.44 M(+13.7%) | -$9.58 M(-15.1%) |
| Mar 2018 | - | -$2.15 M(-10.6%) | -$11.29 M(-5.0%) |
| Dec 2017 | -$11.88 M(-20.3%) | -$2.41 M(-6.7%) | -$11.88 M(-1.0%) |
| Sept 2017 | - | -$2.58 M(-37.9%) | -$12.00 M(-7.3%) |
| June 2017 | - | -$4.15 M(+51.1%) | -$12.95 M(+9.5%) |
| Mar 2017 | - | -$2.75 M(+8.7%) | -$11.83 M(-20.6%) |
| Dec 2016 | -$14.90 M(+5.2%) | -$2.53 M(-28.4%) | -$14.90 M(-11.8%) |
| Sept 2016 | - | -$3.53 M(+16.4%) | -$16.89 M(-0.8%) |
| June 2016 | - | -$3.03 M(-47.9%) | -$17.04 M(-2.0%) |
| Mar 2016 | - | -$5.82 M(+28.6%) | -$17.38 M(+22.8%) |
| Dec 2015 | -$14.16 M(+14.0%) | -$4.52 M(+23.1%) | -$14.16 M(+20.0%) |
| Sept 2015 | - | -$3.67 M(+8.9%) | -$11.80 M(+1.1%) |
| June 2015 | - | -$3.37 M(+30.2%) | -$11.67 M(+1.0%) |
| Mar 2015 | - | -$2.59 M(+19.8%) | -$11.55 M(-7.0%) |
| Dec 2014 | -$12.42 M(-139.6%) | -$2.16 M(-39.0%) | -$12.42 M(-154.8%) |
| Sept 2014 | - | -$3.54 M(+8.9%) | $22.65 M(-10.9%) |
| June 2014 | - | -$3.25 M(-6.0%) | $25.41 M(-10.4%) |
| Mar 2014 | - | -$3.46 M(-110.5%) | $28.35 M(-9.6%) |
| Dec 2013 | $31.36 M(-930.9%) | $32.90 M(-4340.1%) | $31.36 M(-1028.5%) |
| Sept 2013 | - | -$776.00 K(+143.3%) | -$3.38 M(-19.7%) |
| June 2013 | - | -$319.00 K(-28.0%) | -$4.21 M(+2.5%) |
| Mar 2013 | - | -$443.00 K(-75.9%) | -$4.10 M(+8.7%) |
| Dec 2012 | -$3.77 M | -$1.84 M(+14.8%) | -$3.77 M(+52.0%) |
| Sept 2012 | - | -$1.60 M(+635.3%) | -$2.48 M(+32.9%) |
| June 2012 | - | -$218.00 K(+92.9%) | -$1.87 M(-38.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$113.00 K(-79.4%) | -$3.04 M(-9.3%) |
| Dec 2011 | -$3.35 M(-75.1%) | -$549.00 K(-44.4%) | -$3.35 M(-72.7%) |
| Sept 2011 | - | -$988.00 K(-28.8%) | -$12.26 M(-4.1%) |
| June 2011 | - | -$1.39 M(+225.8%) | -$12.78 M(+1.5%) |
| Mar 2011 | - | -$426.00 K(-95.5%) | -$12.59 M(-6.5%) |
| Dec 2010 | -$13.47 M(+107.3%) | -$9.46 M(+524.6%) | -$13.47 M(+139.7%) |
| Sept 2010 | - | -$1.51 M(+26.6%) | -$5.62 M(-11.2%) |
| June 2010 | - | -$1.20 M(-8.3%) | -$6.33 M(+18.7%) |
| Mar 2010 | - | -$1.30 M(-18.8%) | -$5.33 M(-17.9%) |
| Dec 2009 | -$6.50 M(-170.9%) | -$1.60 M(-27.9%) | -$6.50 M(-15.2%) |
| Sept 2009 | - | -$2.23 M(+1007.0%) | -$7.66 M(-190.2%) |
| June 2009 | - | -$201.00 K(-91.8%) | $8.49 M(+36.0%) |
| Mar 2009 | - | -$2.47 M(-11.0%) | $6.25 M(-31.8%) |
| Dec 2008 | $9.16 M(-12.9%) | -$2.77 M(-119.9%) | $9.16 M(-11.9%) |
| Sept 2008 | - | $13.93 M(-669.3%) | $10.40 M(+2.1%) |
| June 2008 | - | -$2.45 M(-640.2%) | $10.18 M(-24.8%) |
| Mar 2008 | - | $453.00 K(-129.5%) | $13.55 M(-42.2%) |
| Dec 2007 | $10.53 M(-2003.3%) | -$1.54 M(-111.2%) | $23.45 M(+45.9%) |
| Sept 2007 | - | $13.71 M(+1392.3%) | $16.07 M(-26.6%) |
| June 2007 | - | $919.00 K(-91.1%) | $21.90 M(-2.6%) |
| Mar 2007 | - | $10.36 M(-216.2%) | $22.49 M(+78.0%) |
| Dec 2006 | -$553.00 K(-98.3%) | -$8.92 M(-145.6%) | $12.63 M(-29.8%) |
| Sept 2006 | - | $19.54 M(+1194.8%) | $17.99 M(-268.1%) |
| June 2006 | - | $1.51 M(+200.6%) | -$10.71 M(-53.0%) |
| Mar 2006 | - | $502.00 K(-114.1%) | -$22.78 M(-29.6%) |
| Dec 2005 | -$32.35 M(-16.1%) | -$3.56 M(-61.2%) | -$32.35 M(-16.0%) |
| Sept 2005 | - | -$9.16 M(-13.3%) | -$38.52 M(-0.4%) |
| June 2005 | - | -$10.57 M(+16.5%) | -$38.67 M(+3.7%) |
| Mar 2005 | - | -$9.07 M(-6.8%) | -$37.30 M(-3.3%) |
| Dec 2004 | -$38.58 M(+76.1%) | -$9.73 M(+4.6%) | -$38.58 M(+8.1%) |
| Sept 2004 | - | -$9.31 M(+1.3%) | -$35.70 M(+10.2%) |
| June 2004 | - | -$9.19 M(-11.2%) | -$32.40 M(+17.4%) |
| Mar 2004 | - | -$10.35 M(+51.1%) | -$27.58 M(+25.9%) |
| Dec 2003 | -$21.91 M(-226.9%) | -$6.85 M(+14.0%) | -$21.91 M(-262.9%) |
| Sept 2003 | - | -$6.01 M(+37.2%) | $13.45 M(-16.8%) |
| June 2003 | - | -$4.38 M(-6.3%) | $16.17 M(-34.8%) |
| Mar 2003 | - | -$4.67 M(-116.4%) | $24.81 M(-3.1%) |
| Dec 2002 | $17.27 M(-208.8%) | $28.51 M(-966.8%) | $25.59 M(-430.5%) |
| Sept 2002 | - | -$3.29 M(-177.2%) | -$7.74 M(-3.0%) |
| June 2002 | - | $4.26 M(-209.5%) | -$7.98 M(-50.6%) |
| Mar 2002 | - | -$3.89 M(-19.3%) | -$16.16 M(+3.9%) |
| Dec 2001 | -$15.87 M(+12.2%) | -$4.82 M(+36.6%) | -$15.56 M(+4.4%) |
| Sept 2001 | - | -$3.53 M(-10.0%) | -$14.90 M(+4.3%) |
| June 2001 | - | -$3.92 M(+19.2%) | -$14.29 M(+25.4%) |
| Mar 2001 | - | -$3.29 M(-21.0%) | -$11.40 M(+38.8%) |
| Dec 2000 | -$14.15 M(+353.4%) | -$4.16 M(+42.6%) | -$8.21 M(+102.9%) |
| Sept 2000 | - | -$2.92 M(+184.2%) | -$4.05 M(+258.9%) |
| June 2000 | - | -$1.03 M(+921.2%) | -$1.13 M(+1021.2%) |
| Mar 2000 | - | -$100.60 K | -$100.60 K |
| Dec 1999 | -$3.12 M | - | - |
FAQ
- What is Cassava Sciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Cassava Sciences?
- What is Cassava Sciences annual EBITDA year-on-year change?
- What is Cassava Sciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Cassava Sciences?
- What is Cassava Sciences quarterly EBITDA year-on-year change?
- What is Cassava Sciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Cassava Sciences?
- What is Cassava Sciences TTM EBITDA year-on-year change?
What is Cassava Sciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of SAVA is -$104.43 M
What is the all time high annual EBITDA for Cassava Sciences?
Cassava Sciences all-time high annual earnings before interest, taxes, depreciation & amortization is $31.36 M
What is Cassava Sciences annual EBITDA year-on-year change?
Over the past year, SAVA annual earnings before interest, taxes, depreciation & amortization has changed by -$25.71 M (-32.66%)
What is Cassava Sciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of SAVA is -$30.36 M
What is the all time high quarterly EBITDA for Cassava Sciences?
Cassava Sciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is $32.90 M
What is Cassava Sciences quarterly EBITDA year-on-year change?
Over the past year, SAVA quarterly earnings before interest, taxes, depreciation & amortization has changed by -$2.88 M (-10.47%)
What is Cassava Sciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of SAVA is -$133.52 M
What is the all time high TTM EBITDA for Cassava Sciences?
Cassava Sciences all-time high TTM earnings before interest, taxes, depreciation & amortization is $31.36 M
What is Cassava Sciences TTM EBITDA year-on-year change?
Over the past year, SAVA TTM earnings before interest, taxes, depreciation & amortization has changed by -$30.98 M (-30.21%)